TY - JOUR
T1 - Functional contribution of α1D-adrenoceptors in the renal vasculature of left ventricular hypertrophy induced with isoprenaline and caffeine in Wistar-Kyoto rats
AU - Ahmad, Ashfaq
AU - Sattar, Munavvar A.
AU - Rathore, Hassaan A.
AU - Abdulla, Mohammad H.
AU - Khan, Safia A.
AU - Abdullah, Nor A.
AU - Kaur, Gurjeet
AU - Johns, Edward J.
N1 - Publisher Copyright:
© National Research Council of Canada. All right reserved.
PY - 2014/10/1
Y1 - 2014/10/1
N2 - This study investigated the role of ±1D-adrenoceptor in the modulation of renal haemodynamics in rats with left ventricular hypertrophy (LVH). LVH was established in Wistar-Kyoto (WKY) rats with isoprenaline (5.0 mg·(kg body mass)-1, by subcutaneous injection every 72 h) and caffeine (62 mg·L-1 in drinking water, daily for 14 days). Renal vasoconstrictor responses were measured for noradrenaline (NA), phenylephrine (PE), and methoxamine (ME) before and immediately after low or high dose intrarenal infusions of BMY 7378, a selective ±1D-adrenoceptor blocker. The rats with LVH had higher mean arterial blood pressure and circulating NA levels, but lower renal cortical blood perfusion compared with the control group (all P < 0.05). In the LVH group, the magnitude of the renal vasoconstrictor response to ME was blunted, but not the response to NA or PE (P < 0.05), compared with the control group (LVH vs. C, 38% vs. 50%). The magnitude of the drop in the vasoconstrictor responses to NA, PE, and ME in the presence of a higher dose of BMY 7378 was significantly greater in the LVH group compared with the control group (LVH vs. C, 45% vs. 25% for NA, 52% vs. 33% for PE, 66% vs. 53% for ME, all P < 0.05). These findings indicate an impaired renal vasoconstrictor response to adrenergic agonists during LVH. In addition, the ±1D-adrenoceptor subtype plays a key role in the modulation of vascular responses in this diseased state.
AB - This study investigated the role of ±1D-adrenoceptor in the modulation of renal haemodynamics in rats with left ventricular hypertrophy (LVH). LVH was established in Wistar-Kyoto (WKY) rats with isoprenaline (5.0 mg·(kg body mass)-1, by subcutaneous injection every 72 h) and caffeine (62 mg·L-1 in drinking water, daily for 14 days). Renal vasoconstrictor responses were measured for noradrenaline (NA), phenylephrine (PE), and methoxamine (ME) before and immediately after low or high dose intrarenal infusions of BMY 7378, a selective ±1D-adrenoceptor blocker. The rats with LVH had higher mean arterial blood pressure and circulating NA levels, but lower renal cortical blood perfusion compared with the control group (all P < 0.05). In the LVH group, the magnitude of the renal vasoconstrictor response to ME was blunted, but not the response to NA or PE (P < 0.05), compared with the control group (LVH vs. C, 38% vs. 50%). The magnitude of the drop in the vasoconstrictor responses to NA, PE, and ME in the presence of a higher dose of BMY 7378 was significantly greater in the LVH group compared with the control group (LVH vs. C, 45% vs. 25% for NA, 52% vs. 33% for PE, 66% vs. 53% for ME, all P < 0.05). These findings indicate an impaired renal vasoconstrictor response to adrenergic agonists during LVH. In addition, the ±1D-adrenoceptor subtype plays a key role in the modulation of vascular responses in this diseased state.
KW - BMY 7378
KW - Methoxamine
KW - Noradrenaline
KW - Phenylephrine
KW - Renal cortical blood perfusion
UR - https://www.scopus.com/pages/publications/84912030287
U2 - 10.1139/cjpp-2014-0236
DO - 10.1139/cjpp-2014-0236
M3 - Article
C2 - 25403946
AN - SCOPUS:84912030287
SN - 0008-4212
VL - 92
SP - 1029
EP - 1035
JO - Canadian Journal of Physiology and Pharmacology
JF - Canadian Journal of Physiology and Pharmacology
IS - 12
ER -